Envestnet Asset Management
LFSC

Envestnet Asset Management’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Envestnet Asset Management’s Portfolio LFSC Stock Details LFSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,267
Closed -$449K – 4844
2025
Q4 		$449K Buy
+12,267
New +$421K ﹤0.01% 3770

Other funds holding LFSC

EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
CCWP
Cedar Cove Wealth Partners Bloomington, Minnesota $213M AUM
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Envestnet Asset Management's LFSC Position: Q1 2026 in Review

Envestnet Asset Management sold out of F/m Emerald Life Sciences Innovation ETF (LFSC) in Q1 2026, closing a stake of 12,267 shares — an estimated $449K sold.

Envestnet Asset Management first reported a position in LFSC in Q4 2025 and held it in 1 quarter. The position peaked at $449K in Q4 2025. 7 funds tracked by Wall St. Rank hold LFSC as of Q1 2026.

  • Envestnet Asset Management reported no remaining F/m Emerald Life Sciences Innovation ETF position as of Q1 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 12,267 F/m Emerald Life Sciences Innovation ETF shares in Q1 2026, an estimated $449K.
  • Envestnet Asset Management first reported a position in F/m Emerald Life Sciences Innovation ETF in Q4 2025 and held it in 1 quarter.
  • Envestnet Asset Management's F/m Emerald Life Sciences Innovation ETF position peaked at $449K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.